| Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery. | |
| | |
MedLine Citation:
|
PMID: 19844176 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The objective of the present study was to compare the efficacy and safety of low-dose unfractionated heparin (UFH) and a low-molecular-weight heparin (LMWH) as prophylaxis against venous thromboembolism in critically ill surgical patients undergoing major surgery. This was a randomized prospective study in which critically ill patients scheduled to undergo major elective surgery were allocated to receive subcutaneously either LMWH once daily and a placebo injection containing sterile 0.9% normal saline or 5000 IU UFH twice daily subcutaneously. Each patient was evaluated postoperatively clinically and confirmed by Doppler study for development of deep vein thrombosis (DVT). One hundred and fifty-six patients completed the protocol. There was similar efficacy of UFH as compared with LMWH in the prophylaxis of DVT. There was also no statistically significant difference in the incidence of major complications in the heparin group as compared with the LMWH group. However, minor hemorrhagic complications such as wound hematoma and surgical site bleeding were significantly more in the heparin group as compared with the LMWH group. Both UFH 5000 units subcutaneously twice daily and LMWH 40 mg once daily provide highly effective and well tolerated prophylaxis for critically ill surgical patients. Considering the advantage of once-daily dosing, a wider adoption of prophylaxis with LMWH may be justified on the basis of patient acceptability and saving of nursing time. |
| | |
Authors:
|
Anushtup De; Prabal Roy; Vinod K Garg; Narendra K Pandey |
Related Documents
:
|
13130446 - Role of low-molecular-weight heparins in the treatment of sudden hearing loss. 9033316 - Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation. 15085466 - Laboratory analysis of blood samples from patients treated with tinzaparin. 12765806 - Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin v... 23127446 - Ceramic-on-ceramic total hip arthroplasty: incidence and risk factors of bearing surfac... 21843716 - Preventive antireflux surgery in neonates with congenital diaphragmatic hernia: a singl... |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis Volume: 21 ISSN: 1473-5733 ISO Abbreviation: Blood Coagul. Fibrinolysis Publication Date: 2010 Jan |
Date Detail:
|
Created Date: 2010-01-12 Completed Date: 2010-03-22 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9102551 Medline TA: Blood Coagul Fibrinolysis Country: England |
Other Details:
|
Languages: eng Pagination: 57-61 Citation Subset: IM |
Affiliation:
|
General and Minimally Invasive Surgery, Fortis Escorts Hospital and Research Centre, Haryana, India. anustupdey@hotmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Anticoagulants / administration & dosage, adverse effects, therapeutic use* Critical Illness* Drug Administration Schedule Enoxaparin / administration & dosage, adverse effects, therapeutic use* Female Follow-Up Studies Hemorrhage / chemically induced, epidemiology Heparin / administration & dosage, adverse effects, therapeutic use* Humans Injections, Subcutaneous Male Middle Aged Postoperative Complications / chemically induced, epidemiology, prevention & control*, ultrasonography Premedication* Prospective Studies Risk Factors Surgical Procedures, Elective* Venous Thrombosis / prevention & control*, ultrasonography |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Enoxaparin; 9005-49-6/Heparin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Carbon monoxide releasing molecule-2 decreases thick diameter fibrin fibre formation in normal and f...
Next Document: An update on robotic thoracic surgery and anesthesia.